Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cross Atlantic Partners (CAP) was a specialized venture capital and private equity firm that focused primarily on the healthcare and life sciences sectors. Founded in the early 1990s and based in New York, the firm operated as a merchant bank and investment manager, often taking lead roles in financing emerging biotechnology and medical device companies. CAP was notable for its hands-on approach to company building, providing both capital and strategic advisory services to its portfolio companies. While the firm is no longer actively making new investments under its original structure, it played a significant role in the early development of several prominent healthcare entities, including Integra LifeSciences and AtheroGenics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cross Atlantic Partners.